|
🐬
|
Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971
Libby Ellis,
M. Shale,
M. Coleman
|
7 |
2010 |
7
🐬
|
|
🦁
|
CD4+ T-cell subsets in intestinal inflammation
M. Shale,
Chris Schiering,
F. Powrie
|
7 |
2013 |
7
🦁
|
|
🦁
|
Hepatosplenic T cell lymphoma in inflammatory bowel disease
M. Shale,
E. Kanfer,
R. Panaccione,
Subrata Ghosh
|
7 |
2008 |
7
🦁
|
|
🦁
|
Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease
M. Shale,
C. Seow,
C. Coffin,
G. Kaplan,
R. Panaccione,
Subrata Ghosh
|
6 |
2010 |
6
🦁
|
|
🐜
|
T-bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine
10 auth.
T. Krausgruber,
Chris Schiering,
Krista Adelmann,
O. Harrison,
Agnieszka Chomka,
C. Pearson,
...
Philip P. Ahern,
M. Shale,
M. Oukka,
F. Powrie
|
6 |
2016 |
6
🐜
|
|
🐜
|
Defining the microbial transcriptional response to colitis through integrated host and microbiome profiling
10 auth.
N. Ilott,
J. Bollrath,
C. Danne,
Chris Schiering,
M. Shale,
Krista Adelmann,
...
T. Krausgruber,
A. Heger,
D. Sims,
F. Powrie
|
5 |
2016 |
5
🐜
|
|
🦁
|
How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease
M. Shale,
S. Ghosh
|
5 |
2009 |
5
🦁
|
|
🦁
|
Isotretinoin and intestinal inflammation: what gastroenterologists need to know
M. Shale,
G. Kaplan,
R. Panaccione,
Subrata Ghosh
|
5 |
2009 |
5
🦁
|
|
🦁
|
The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease.
M. Shale
|
5 |
2009 |
5
🦁
|
